MedTrace Logo

Melatonin Treatment for Night-Eating Syndrome

NCT02500017 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2018-01-23

No results posted yet for this study

Summary

This is an 8-week randomized, double-blind, placebo-controlled, parallel, fixed-dose pilot clinical trial to test the effectiveness of melatonin treatment versus placebo on symptoms of Night Eating Syndrome (NES). The investigators will also look at the effect of melatonin treatment on weight, metabolic parameters and sleep parameters in individuals with NES.

Conditions

  • Night-eating Syndrome

Interventions

DIETARY_SUPPLEMENT

Melatonin

5mg rapid release melatonin capsule

OTHER

Placebo

matching placebo capsule

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Cenk Tek, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-24
Primary Completion
2017-04-25
Completion
2017-04-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02500017 on ClinicalTrials.gov